Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 29;12(3):256.
doi: 10.3390/vaccines12030256.

Barriers to and Facilitators for Accessing HPV Vaccination in Migrant and Refugee Populations: A Systematic Review

Affiliations
Review

Barriers to and Facilitators for Accessing HPV Vaccination in Migrant and Refugee Populations: A Systematic Review

Davide Graci et al. Vaccines (Basel). .

Abstract

Human papillomavirus (HPV) is the most prevalent sexually transmitted virus globally and a primary cause of cervical cancer, which ranks fourth among tumors in both incidence and mortality. Despite the availability of effective vaccines worldwide, HPV vaccination rates vary, especially among migrant and refugee populations. Indeed, migrant status may act as a determinant against accessing vaccinations, among many other factors. The objective of this paper is to evaluate barriers to and facilitators for accessing HPV vaccination in migrant and refugee populations. A systematic review of the existing peer-reviewed academic literature was conducted according to the PRISMA 2020 guidelines in which we examined thirty-four studies to evaluate HPV vaccination rates in these populations and identify factors acting as barriers or facilitators. Key determinants include socio-economic status and health literacy. Communication barriers, including language and cultural factors, also impact access to information and trust in the health workforce. Understanding and considering these factors is crucial for developing proper and inclusive vaccination strategies to ensure that no population is overlooked.

Keywords: HPV; migrants; prevention; public health; refugees; social determinants; vaccination; vaccination strategies; vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram for new systematic reviews. * Eight pairs of human reviewers selected, based on the title and abstract, only the publications that contained outcome measures related to HPV vaccination. ° Abstract not available (n = 16); language of the study was not English (n = 7); target population other than migrants and refugees (n = 21); outcome not related to HPV vaccination (n = 28); review, systematic review, meta-analysis, trial, and pre–post intervention study (n = 81). ** Four pairs of human reviewers selected the publications on the basis of the full text [18].

References

    1. European Centre for Disease Prevention and Control . Guidance on HPV Vaccination in EU Countries: Focus on Boys, People Liv-ing with HIV and 9 Valent HPV Vaccine Introduction. Publications Office; Luxembourg: 2020. [(accessed on 26 December 2023)]. Available online: https://data.europa.eu/doi/10.2900/71487. - DOI
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Wardak S. Human Papillomavirus (HPV) and cervical cancer. Med. Dosw. Mikrobiol. 2016;68:73–84. - PubMed
    1. Yang D.X., Soulos P.R., Davis B., Gross C.P., Yu J.B. Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence. Am. J. Clin. Oncol. 2018;41:289–294. doi: 10.1097/COC.0000000000000264. - DOI - PMC - PubMed
    1. Mix J.M., Van Dyne E.A., Saraiya M., Hallowell B.D., Thomas C.C. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15–29 Years in the United States, 1999–2017: An Ecologic Study. Cancer Epidemiol. Biomark. Prev. 2021;30:30–37. doi: 10.1158/1055-9965.EPI-20-0846. - DOI - PMC - PubMed

LinkOut - more resources